Clinical Trial Update: Pharmacological Ascorbate for Lung Cancer [Phase 2]

View source ↗

Summary

This report indicates the completion of a Phase 2 trial evaluating pharmacological ascorbate for non-small cell lung cancer, with results posted 2024-04-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pharmacological ascorbate (ascorbate)

Snippet

Sponsor: Joseph J. Cullen, MD, FACS | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2024-04-17